BioAtla, Inc. (BCAB) SEC Filings & Financial Intelligence
BioAtla, Inc. (BCAB) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BCAB
CIK: 1826892
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerBrian Valenzuela
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-23 | 8-K | 0001193125-26-407817 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380486 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380482 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380479 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-26 | FORM 8-K | 0001539497-26-002373 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349542 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-16 | 8-K | 0001193125-26-306117 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-11 | 4 | 0001193125-26-259699 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-12 | 4 | 0001193125-26-259702 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-11 | 4 | 0001193125-26-259689 | View SEC Doc Filr Page |
| ARS | 2026-06-03 | 2025-12-31 | ARS | 0001193125-26-255438 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-03 | — | DEFA14A | 0001193125-26-255434 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-03 | 2026-06-03 | DEF 14A | 0001193125-26-255422 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-226631 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-29 | 2025-12-31 | 10-K/A | 0001193125-26-191493 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-04-02 | 8-K | 0001193125-26-140053 | View SEC Doc Filr Page |
| S-8 | 2026-03-31 | — | S-8 | 0001193125-26-134492 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001193125-26-134499 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-31 | 8-K | 0001193125-26-134501 | View SEC Doc Filr Page |
| 8-K | 2026-03-23 | 2026-03-17 | 8-K | 0001193125-26-119698 | View SEC Doc Filr Page |
| 424B2 | 2026-03-20 | — | 424B2 | 0001539497-26-000972 | View SEC Doc Filr Page |
| 424B2 | 2026-03-13 | — | PROSPECTUS SUPPLEMENT NO. 2 | 0001539497-26-000924 | View SEC Doc Filr Page |
| 4 | 2026-03-12 | 2026-03-10 | 4 | 0001193125-26-104136 | View SEC Doc Filr Page |
| 4 | 2026-03-12 | 2026-03-11 | 4 | 0001193125-26-104134 | View SEC Doc Filr Page |
| 4 | 2026-03-12 | 2026-03-10 | 4 | 0001193125-26-104132 | View SEC Doc Filr Page |